Forte Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
FBRX Nasdaq 8731 https://www.fortebiorx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Forte Biosciences Inc

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting - Sep 14th, 2023 2:50 pm
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom - Sep 6th, 2023 7:15 pm
Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders - Aug 25th, 2023 12:00 pm
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update - Aug 14th, 2023 8:01 pm
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102 - Aug 1st, 2023 8:01 pm
Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors - Jun 20th, 2023 12:00 pm
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - May 19th, 2023 8:01 pm
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update - May 15th, 2023 8:01 pm
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update - Mar 31st, 2023 8:05 pm
Mr. David Gryska Appointed to Forte Biosciences Board of Directors - Jan 12th, 2023 9:05 pm
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors - Nov 14th, 2022 9:01 pm
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update - Nov 14th, 2022 9:01 pm